Results 5,961-5,980 of 9,393 for speaker:Alex White

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: That may be so.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: To be clear, I do not propose to introduce an amendment to the Pharmacy Act 2007 regarding the issue of bankruptcy in the context of this legislation.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: The name is being changed to bring the board more in line with its extended functions. It will take account of the additional powers and requirements set out in the Act. It is more appropriate for the board to be known as the health products regulatory authority and thus take account of its new functions. It will include medical devices in general. The title "health products" has a...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I was going to wait and listen to the basis for the Deputy's proposal because it was not entirely clear to me. Schedule 1 sets out procedural provisions relating to certain decisions of the IMB and HSE under the Bill. Part 1 of the Schedule refers to the procedural provisions relating to the requirement, set out under section 6(1), that the IMB give notice in writing of a relevant decision...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I move amendment No. 12: In page 27, subsection (2), lines 28 to 30, to delete paragraphs (d) and (e)and substitute the following:"(d)the potential budget impact of the item if it were to become a listed item, (e)the ability of suppliers of the item to meet patient demand for the item if it were to become a listed item, (f) the resources available to the Executive, and (g)the terms of any...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I refer to paragraph (c), which deals with the potential therapeutic benefits of the item for patients likely to use the item if it were to become a listed item. It seems to me that this addresses the issue.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: We are considering the aspect of the patient's welfare with regard to the effect or impact of particular drugs. It is the potential therapeutic benefit of the item for the patient who is likely to use it.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I draw the attention of the Deputy and the committee to Part 3 of the Schedule setting out general criteria, wherein it is stated that the executive shall have regard to the health needs of the public.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I move amendment No. 13: In page 28, subsection (3), lines 39 to 41, to delete paragraphs (d) and (e) and substitute the following:"(d) the relevant prices of therapeutically similar listed items, (e) the resources available to the Executive, and (f)the terms of any agreement in place (whether entered into before, on or after the commencement of this section) between the Executive and any...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I can reply in the affirmative to both questions.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: That is my understanding.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I move amendment No. 14: In page 34, lines 1 to 4, to delete paragraph (c) and substitute the following:"(c) in section 35(1) by inserting the following after paragraph (e):"(ea) a failure to comply with Chapter 2 or 3 of Part 2, or Part 3, of the Health (Pricing and Supply of Medical Goods) Act 2013, (eb)a failure to comply with any duties referred to in section 18(1A) imposed on the...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: The list.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I retain my respectful view that section 17 deals with the maintenance of the list. The Deputies may well have raised an issue in respect of which I could perhaps seek further clarification between now and Report Stage as to precisely the technical process by which changes are made to the list. Deputy Billy Kelleher inquired as to whether prescribers and dispensers would be obliged to...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I understand the point. However, section 19 deals with the process by which the HSE will make decisions and revert to suppliers on such decisions. I respectfully suggest that what Deputy Billy Kelleher proposes in his amendments is excessive and unnecessary, particularly if he is advocating that all prescribers and pharmacists and, as Deputy Caoimhghín Ó Caoláin recommended,...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I move amendment No. 11: In page 25, lines 33 to 36, to delete subsection (3) and substitute the following:"(3) The Executive may—(a) in the case of a relevant decision which falls within paragraph (a) or (e) of the definition of "relevant decision" in subsection (8), specify a date, or the occurrence of an event, from which the relevant decision shall take effect, and (b) in the case...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: It most certainly does. "Prescriber" includes a GP.

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: Persons with the power to prescribe include GPs. I share Deputy Kelleher's concern about benzodiazepines, which Deputy Ó Caoláin and others share. In respect of the Chairman's comments about pharmacists, we are enhancing the role and strengthening the hand of the pharmacist. With regard to pharmacists declining to dispense, there was a concern that this would affect the health of...

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I move amendment No. 8: In page 24, subsection (3)(b), lines 33 and 34, to delete all words from and including "the" in line 33 down to and including "run" in line 34 and substitute the following:"the running of the period of 180 days referred to in subsection (2) is, upon the giving of the notice referred to in paragraph (a) to the applicant, suspended".

Committee on Health and Children: Select Sub-Committee on Health: Health (Pricing and Supply of Medical Goods) Bill 2012: Committee Stage (19 Mar 2013)

Alex White: I propose to take amendments Nos. 9 and 10 together. Part 4 of the Bill sets out statutory procedures concerning the supply and reimbursement of medicines and other items to patients under the general medical scheme and community drugs schemes. Section 19 of the Bill sets out the action to be taken by the HSE where it makes a relevant decision under section 18 of the Bill, namely, to add or...